Table 2.

ARIA‐EAACI research questions

Real‐world studies need to be carried out on a large number of unselected patients to assess
1	Impact of COVID‐19 on asthma control
2	Impact of COVID‐19 respiratory symptoms on severe asthma
3	Impact of severe asthma on COVID‐19 occurrence and/or severity of pneumonia
4	Impact of multimorbidities on asthmatic patients for the control of asthma during COVID‐19
5	Serologic studies should be performed to assess whether seroconversion and its duration differ in asthmatic and non‐asthmatic subjects
6	The phenotype of asthma (allergic, neutrophilic, age….) should be studied
7	In adult patients, studies should clarify whether asthmatic patients with COVID‐19 have isolated asthma or asthma in the context of multimorbidity, particularly in the context of high blood pressure, obesity and diabetes mellitus
8	Role of pollen season on COVID‐19 severity